Notice of Knight Therapeutics' Fourth Quarter and Year End 2023 Results Conference Call
14 mars 2024 07h30 HE
|
Knight Therapeutics
MONTREAL, March 14, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its fourth quarter and...
SMDG Announces Appointment of Industry Leader Dr. Zsuzsanna Devecseri to the Board of Directors
14 mars 2024 05h00 HE
|
S. M. Discovery Group (SMDG)
SMDG Announces Appointment of Industry Leader Dr. Zsuzsanna Devecseri to the Board of Directors
PRISM MarketView Highlights Work of Emerging Companies on Rare Disease Day
29 févr. 2024 09h54 HE
|
PRISM MarketView
PRISM MarketView Highlights Work of Emerging Companies on Rare Disease Day
Knight Therapeutics Announces Launch of Minjuvi® in Brazil
29 févr. 2024 07h30 HE
|
Knight Therapeutics
MONTREAL, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today the launch of Minjuvi®...
With Extensive Two-Year Revenue Growth, ValueSelling Associates is Selected to Inc. Magazine’s List of the Pacific Region’s Fastest-Growing Private Companies
28 févr. 2024 13h09 HE
|
ValueSelling Associates, Inc.
ValueSelling Associates has been selected to the Inc. 5000 Regionals Pacific list, showcasing the fastest-growing Pacific private companies.
Knight Therapeutics Inc. Celebrates its First Decade of Success
28 févr. 2024 07h30 HE
|
Knight Therapeutics
MONTREAL, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that it is marking its 10-year...
Digital Therapeutics Market Size to Reach US$24.5 Billion by 2030, Forecasts Fairfield Market Research in a New Report
27 févr. 2024 07h32 HE
|
Fairfield Consultancy Services OPC Pvt Ltd
London, Feb. 27, 2024 (GLOBE NEWSWIRE) -- As indicated by a newly published report by Fairfield Market Research, the global market for digital therapeutics is poised to witness staggering growth,...
Knight Therapeutics Announces Regulatory Submission of Fostamatinib in Brazil
21 févr. 2024 17h30 HE
|
Knight Therapeutics
MONTREAL, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate,...
Global Ophthalmic Drugs Market Size is Estimated to Reach USD 62.55 billion by 2030, Growing at a CAGR of 7.4%: Straits Research
21 févr. 2024 10h20 HE
|
Straits Research
New York, United States, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Anti-infectives in a product designed specifically to be injected into or applied to the eye or eyes are known as ophthalmic...
60 Degrees Pharmaceuticals to Sponsor Pre-Clinical Studies of Tafenoquine Use in Candida spp, Including Candida auris
20 févr. 2024 07h59 HE
|
Sixty Degrees Pharmaceuticals
60 Degrees Pharmaceuticals will Sponsor Pre-Clinical Studies ofTafenoquine Use in Candida spp, Including Candida auris